| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 6, Issue 1 59-68, Copyright © 1995 by American Association of Cancer Research
ARTICLES |
J Bies, R Mukhopadhyaya, J Pierce and L Wolff
Laboratory of Genetics, National Cancer Institute, Bethesda, Maryland 20892.
In murine leukemia virus-induced myeloid leukemias, insertional mutagenesis of the c-myb locus has been shown to occur frequently. Proto-oncogene activation is achieved in most leukemias by integration of murine leukemia virus upstream of exons 3 or 4 or by integration into exon 9 with consequent truncation of the protein. The present study investigates the effect of ectopic expression of full-length c-myb or c-myb containing amino- or carboxyl-terminal truncations (minus 47 and 248 amino acids, respectively) on granulocyte differentiation in vitro. Recombinant myb retroviruses were used to infect an interleukin 3-dependent progenitor cell line, 32Dcl3, which undergoes terminal differentiation to mature neutrophilic granulocytes in the presence of granulocyte colony-stimulating factor. Overexpression of c-myb did not abrogate the interleukin 3 dependency of the parental cell line. However, cells expressing all forms of c-myb were blocked at an intermediate stage of granulocyte differentiation and continued to proliferate in the presence of granulocyte colony-stimulating factor. After 14 days in medium with granulocyte colony-stimulating factor, myb-expressing cultures predominantly consisted of promyelocytes with some myelocytes and almost undetectable numbers of neutrophilic granulocytes. This suggested that early stages of granulocyte differentiation were not inhibited, a finding that was further supported by the induction of myeloperoxidase, a biochemical marker of promyelocytes. Interestingly, the expression of lactoferrin, known to be a marker of late stages of granulocyte differentiation, was completely inhibited in the cells infected with myb viruses. It was concluded that c-myb expression blocked granulocyte differentiation to the terminal mitotic stages and that deletion of the NH2-terminal 47 amino acids and/or the COOH-terminal 248 amino acids of c-myb neither enhanced nor diminished this effect.
This article has been cited by other articles:
![]() |
Y. Nakata, S. Shetzline, C. Sakashita, A. Kalota, R. Rallapalli, S. I. Rudnick, Y. Zhang, S. G. Emerson, and A. M. Gewirtz c-Myb Contributes to G2/M Cell Cycle Transition in Human Hematopoietic Cells by Direct Regulation of Cyclin B1 Expression Mol. Cell. Biol., March 15, 2007; 27(6): 2048 - 2058. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Markus, M. T. Garin, J. Bies, N. Galili, A. Raza, M. J. Thirman, M. M. Le Beau, J. D. Rowley, P. P. Liu, and L. Wolff Methylation-Independent Silencing of the Tumor Suppressor INK4b (p15) by CBF{beta}-SMMHC in Acute Myelogenous Leukemia with inv(16) Cancer Res., February 1, 2007; 67(3): 992 - 1000. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Nemeth, A. P. Cline, S. M. Anderson, L. J. Garrett-Beal, and D. M. Bodine Hmgb3 deficiency deregulates proliferation and differentiation of common lymphoid and myeloid progenitors Blood, January 15, 2005; 105(2): 627 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kumar, S. J. Baker, C. M. Lee, and E. P. Reddy Molecular Mechanisms Associated with the Regulation of Apoptosis by the Two Alternatively Spliced Products of c-Myb Mol. Cell. Biol., September 15, 2003; 23(18): 6631 - 6645. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kumar, C. M. Lee, and E. P. Reddy c-Myc Is Essential but Not Sufficient for c-Myb-mediated Block of Granulocytic Differentiation J. Biol. Chem., March 21, 2003; 278(13): 11480 - 11488. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zheng, A. D. Friedman, and D. Small Targeted inhibition of FLT3 overcomes the block to myeloid differentiation in 32Dcl3 cells caused by expression of FLT3/ITD mutations Blood, December 1, 2002; 100(12): 4154 - 4161. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-f. Wang and A. D. Friedman CCAAT/enhancer-binding proteins are required for granulopoiesis independent of their induction of the granulocyte colony-stimulating factor receptor Blood, April 15, 2002; 99(8): 2776 - 2785. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Lekstrom-Himes The Role of C/EBP{{varepsilon}} in the Terminal Stages of Granulocyte Differentiation Stem Cells, February 1, 2001; 19(2): 125 - 133. [Abstract] [Full Text] |
||||
![]() |
M. Arsura, C. S. Hofmann, J. Golay, M. Introna, and G. E. Sonenshein A-myb rescues murine B-cell lymphomas from IgM-receptor-mediated apoptosis through c-myc transcriptional regulation Blood, August 1, 2000; 96(3): 1013 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schmidt, V. Nazarov, L. Stevens, R. Watson, and L. Wolff Regulation of the Resident Chromosomal Copy of c-myc by c-Myb Is Involved in Myeloid Leukemogenesis Mol. Cell. Biol., March 15, 2000; 20(6): 1970 - 1981. [Abstract] [Full Text] |
||||
![]() |
J. Bies, V. Nazarov, and L. Wolff Identification of Protein Instability Determinants in the Carboxy-Terminal Region of c-Myb Removed as a Result of Retroviral Integration in Murine Monocytic Leukemias J. Virol., March 1, 1999; 73(3): 2038 - 2044. [Abstract] [Full Text] |
||||
![]() |
C. H. Woo, L. Sopchak, and J. S. Lipsick Overexpression of an Alternatively Spliced Form of c-Myb Results in Increases in Transactivation and Transforms Avian Myelomonoblasts J. Virol., August 1, 1998; 72(8): 6813 - 6821. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Inoue, H. Tamaki, H. Ogawa, Y. Oka, T. Soma, T. Tatekawa, Y. Oji, A. Tsuboi, E. H. Kim, M. Kawakami, et al. Wilms' Tumor Gene (WT1) Competes With Differentiation-Inducing Signal in Hematopoietic Progenitor Cells Blood, April 15, 1998; 91(8): 2969 - 2976. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Tavner, R. Simpson, S. Tashiro, D. Favier, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, E. M. Macmillan, J. Lutwyche, R. A. Keough, et al. Molecular Cloning Reveals that the p160 Myb-Binding Protein Is a Novel, Predominantly Nucleolar Protein Which May Play a Role in Transactivation by Myb Mol. Cell. Biol., February 1, 1998; 18(2): 989 - 1002. [Abstract] [Full Text] |
||||
![]() |
I.-H. O. a. E. P. Reddy The C-Terminal Domain of B-Myb Acts As a Positive Regulator of Transcription and Modulates Its Biological Functions Mol. Cell. Biol., January 1, 1998; 18(1): 499 - 511. [Abstract] [Full Text] |
||||
![]() |
I.-H. Oh and E. P. Reddy Murine A-myb Gene Encodes a Transcription Factor, Which Cooperates with Ets-2 and Exhibits Distinctive Biochemical and Biological Activities from c-myb J. Biol. Chem., August 22, 1997; 272(34): 21432 - 21443. [Abstract] [Full Text] [PDF] |
||||
![]() |
A B Dash, F C Orrico, and S A Ness The EVES motif mediates both intermolecular and intramolecular regulation of c-Myb. Genes & Dev., August 1, 1996; 10(15): 1858 - 1869. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |